Introduction: Osteocalcin (OC) is a bone-derived protein that undergoes vitamin K-dependent carboxylation. The undercarboxylated form of the protein (ucOC) is released in the circulation during the process of bone resorption. Experimental studies on mice and rats have revealed that ucOC is involved in the regulation of energy homeostasis, linking in this way the bone, pancreas, and adipose tissue metabolism. Experimental studies suggest no hormonal role for the carboxylated form (cOC) of the protein.
Aim: In the current study we aimed to examine the levels of OC in its carboxylated and undercarboxylated form in patients with type 2 diabetes and control subjects, and to compare the vitamin K status between the two groups.
Materials and Methods: The present cross-sectional study involved a sample of 46 adults type 2 diabetes patients and a control group of 19 individuals. The carboxylated and undercarboxylated forms of OC were measured in serum by using highly sensitive sandwich-type enzyme immunoassay kits. Vitamin K status was evaluated by the ratio ucOC/cOC. Student’s two-tailed unpaired t-test was used to compare the groups.
Results: UcOC and cOC serum levels were significantly lower in patients with type 2 diabetes compared to controls. We found no difference in the vitamin K status between the groups.
Conclusion: Our results show that OC might be involved in the regulation of carbohydrate metabolism. In humans, it appears that the carboxylation state might not be essential for the hormonal role of the protein as in mice and rats.
Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989; 69(3):990-1047.
Atalay S, Elci A, Kayadibi H, Onder CB, Aka N. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med. 2012;32(1):23-30. doi: 10.3343/alm.2012.32.1.23.
Jagtap VR, Ganu JV, Nagane NS. BMD and serum intact osteocalcin in postmenopausal osteoporosis women. Indian J Clin Biochem. 2011; 26(1):70-3. doi: 10.1007/s12291-010-0074-2.
Truong JT, Fu X, Saltzman E, Al Rajabi A, Dallal GE, Gundberg CM, et al. Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J Nutr. 2012;142(5):936-41. doi: 10.3945/jn.111.154807.
Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients. 2016; 8(1):8. doi:10.3390/nu8010008.
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996; 382(6590):448-52. doi: 10.1038/382448a0.
Lee N, Sowa H, Hinoi E, Ferron M, Ahn J, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456–69. doi: 10.1016/j.cell.2007.05.047.
Ferron M, McKee M, Levine R, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50(2):568–75. doi: 10.1016/j.bone.2011.04.017.
Gancheva S, Galunska B, Zhelyazkova-Savova M. Osteocalcin in a rat model of metabolic syndrome. Adipobiology. 2015; 7:31-6. doi: 10.14748/adipo.v7.1558.
Gancheva S, Zhelyazkova-Savova M. Are bisphosphonates associated with adverse metabolic and cognitive effects? A study in intact rats and rats fed high-fat high-fructose diet. Calcif Tissue Int. 2020; 107(1):41-51. doi: 10.1007/s00223-020-00684-5.
Sanchez-Enriquez S, Ballesteros-Gonzalez IT, Villafán-Bernal JR, Pascoe-Gonzalez S, Rivera-Leon EA, Bastidas-Ramirez BE, et al. Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects. World J Diabetes. 2017;8(1):11-7. doi: 10.4239/wjd.v8.i1.11.
Riquelme-Gallego B, García-Molina L, Cano-Ibáñez N, Sánchez-Delgado G, Andújar-Vera F, García-Fontana C, et al. Circulating undercarboxylated osteocalcin as estimator of cardiovascular and type 2 diabetes risk in metabolic syndrome patients. Sci Rep. 2020;10(1):1840. doi: 10.1038/s41598-020-58760-7.
Liu DM, Guo XZ, Tong HJ, Tao B, Sun LH, Zhao HY, et al. Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos Int. 2015;26(12):2823-33. doi: 10.1007/s00198-015-3197-8.
Hwang Y, Jeong I, Ahn K, Chung H. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009;25(8):768–72. doi: 10.1002/dmrr.1045.
Shea M, Gundberg C, Meigs J, Dallal G, Saltzman E, Yoshida M, et al. Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009;90(5):1230-5. doi: 10.3945/ajcn.2009.28151.
Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr. 2012;3(2):149-57. doi: 10.3945/an.112.001834.
Zhelyazkova-Savova M, Gancheva S, Galunska B, Gerova D. Vitamin K: The new faces of an old friend – a role in bone and vascular health. Biomed Rev. 2017; 28:70-90. doi: 10.14748/bmr.v28.4453
McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr. 2009;90(4):889-907. doi: 10.3945/ajcn.2009.27930.
Pan Y, Jackson R. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr. 2009;28(4):369-79. doi: 10.1080/07315724.2009.10718099.
Beulens J, van der A D, Grobbee D, Sluijs I, Spijkerman A, van der Schouw Y. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care. 2010;33(8):1699-705. doi: 10.2337/dc09-2302.
Ibarrola-Jurado N, Salas-Salvado J, Martinez-Gonzalez M, Bullo M. Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease. Am J Clin Nutr. 2012;96(5):1113-8. doi: 10.3945/ajcn.111.033498.
Zwakenberg SR, Remmelzwaal S, Beulens JWJ, Booth SL, Burgess S, Dashti HS, et al. Circulating phylloquinone concentrations and risk of type 2 diabetes: A Mendelian randomization study. Diabetes. 2019;68(1):220–5. doi: 10.2337/db18-0543.
Takaya J, Tanabe Y, Kuroyanagi Y, Kaneko K. Decreased undercarboxylated osteocalcin in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2016;29(8):879-84. doi: 10.1515/jpem-2015-0417.
Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Lumpkin CK Jr, Fowlkes JL. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int. 2012;23(6):1799-806. doi: 10.1007/s00198-011-1807-7.
Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho R, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296–308. doi: 10.1016/j.cell.2010.06.003.
Wei J, Hanna T, Suda N, Karsenty G, Ducy P. Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes. 2014;63(3):1021–31. doi: 10.2337/db13-0887.
Sabek OM, Redondo MJ, Nguyen DT, Beamish CA, Fraga DW, Hampe CS, et al. Serum C-peptide and osteocalcin levels in children with recently diagnosed diabetes. Endocrinol Diabetes Metab. 2019;3(1):e00104. doi: 10.1002/edm2.104.
Razny U, Fedak D, Kiec-Wilk B, Goralska J, Gruca A, Zdzienicka A, et al. Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes. Diabetes Metab Res Rev. 2017;33(3):e2862. doi: 10.1002/dmrr.2862.
Knapen MHJ, Schurgers LJ, Shearer MJ, Newman P, Theuwissen E, Vermeer C. Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight. Br J Nutr. 2012; 108(6):1017–24. doi: 10.1017/S000711451100626X.
Lu C, Ivaska KK, Alen M, Wang Q, Törmäkangas T, Xu L, et al. Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. J Clin Endocrinol Metab. 2012;97(11):4106-14. doi: 10.1210/jc.2012-2045.
Manna P, Kalita J. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review. Nutrition. 2016; 32(7-8):732-9. doi: 10.1016/j.nut.2016.01.011.
Li Y, Chen JP, Duan L, Li S. Effect of vitamin K2 on type 2 diabetes mellitus: A review. Diabetes Res Clin Pract. 2018;136:39-51. doi: 10.1016/j.diabres.2017.11.020.
Ho H-J, Komai M, Shirakawa H. Beneficial effects of vitamin K status on glycemic regulation and diabetes mellitus: A mini-review. Nutrients. 2020; 12(8):2485. doi: 10.3390/nu12082485.
Email this article (Login required) 
